Cargando…
Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
BACKGROUND/AIMS: Several recent studies have reported that the early use of infliximab (IFX) improves the prognosis of Crohn's disease (CD). However, no data are available from Asian populations, as the forementioned studies have all been conducted in Western countries. The aim of the current s...
Autores principales: | Kim, Nam Hee, Jung, Yoon Suk, Moon, Chang Mo, Lee, Shin Yeong, Kim, Eun Ran, Kim, Young Ho, Lee, Chang Kyun, Lee, Suck Ho, Kim, Jae Hak, Huh, Kyu Chan, Yoon, Soon Man, Song, Hyun Joo, Boo, Sun-Jin, Jang, Hyun Joo, Kim, You Sun, Lee, Kang-Moon, Shin, Jeong Eun, Park, Dong Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214954/ https://www.ncbi.nlm.nih.gov/pubmed/25374493 http://dx.doi.org/10.5217/ir.2014.12.4.281 |
Ejemplares similares
-
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
por: Choi, Chang Hwan, et al.
Publicado: (2016) -
Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, between CT-P13 and Originator Infliximab
por: Park, Jihye, et al.
Publicado: (2023) -
Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017) -
The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014) -
Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
por: Kim, Eun Soo, et al.
Publicado: (2016)